German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing...
from NDTV News - World-news https://ift.tt/3s4efbK
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron https://ift.tt/eA8V8J
By -
December 15, 2021
0
Tags:
Post a Comment
0Comments